From Gold to BronzeNo matters the reasons we invoke and the facts we put in front of their eyes, there will be always some people who are in a denial phase. Share price is at its very low and they are still saying that it is an opportunity for some to buy more. I garantee the share price will hit $0,8 before end of this year, Then maybe it will be an opportunity to inject some money by mid january 2023. At least this is my posture right now. I will buy 30k shares at $0,8 to average at $3 and ignore TH for a while, counting on a legacy drugs to push the share price around $3. Oncology program was a nightmare, NASH is an impossible dream. Paul Levesque and the whole management are just good to make bronze from gold.